IL22 and breast carcinoma: The influence of IL-22 on hyperplasia, adenoma, early carcinoma, and late carcinoma stages of cancer was investigated using IL-22−/−/MMTV-PyMT spontaneous breast cancer mouse model showing that it is necessary for malignant transformation of cancer cells which is the critical stage for metastasis.